Context Therapeutics (CNTX) Preferred Shares Issued (2021)

Context Therapeutics has disclosed Preferred Shares Issued across 1 years of filings, most recently posting $1.9 million for Q2 2021.

• Preferred Shares Issued for Q2 2021 came in at $1.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $1.9 million (changed N/A YoY), and the FY2021 annual result was $5.0 million, up 9865.67% from the prior year.
• Preferred Shares Issued came in at $1.9 million for Q2 2021 at Context Therapeutics, down from $3.0 million in the prior quarter.
• In the past five years, Preferred Shares Issued ranged from a high of $3.0 million in Q1 2021 to a low of $1.9 million in Q2 2021.